Ying Ye
Fondateur chez Xiamen LP Pharmaceutical Co., Ltd.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Xin Yi Xu | F | 47 |
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 ans |
| Hai Jian Zhu | M | 59 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 ans |
| Yuan Qing Luo | M | 56 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
| Chao Lin Chen | M | 51 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
| San Ming Li | M | 67 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 3 ans |
| Feng Tu | M | 50 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 ans |
| Shang Ying Ge | F | 37 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 10 ans |
| Ke Xiang Zhou | M | 60 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 6 ans |
| Shuang Wen Zhang | M | 53 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
| Yun Xia Yang | F | 51 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
| Hua Yi | M | 50 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
| Yuan Tao Song | M | 39 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 ans |
| Lin Hui Cai | F | 38 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 11 ans |
| Ning Yao Lin | M | 53 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | 4 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Phouphet Kyophilavong | M | 50 |
Osaka University
| 6 ans |
| Yutaro Murakami | M | - |
Osaka University
| 3 ans |
| Yosuke Hirai | M | - |
Osaka University
| 4 ans |
| Kamal Uddin | M | 57 |
Osaka University
| 3 ans |
| Murayama Masato | M | - |
Osaka University
| 4 ans |
| Katsuya Kitano | M | 48 |
Osaka University
| 4 ans |
| Cheng Ye | M | 53 |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | - |
| Masanori Yamato | M | - |
Osaka University
| 3 ans |
| Osamu Yamazaki | M | 62 |
Osaka University
| 3 ans |
| Tsuyoshi Okuno | M | - |
Osaka University
| 4 ans |
| Kiyohito Nagata | M | 66 |
Osaka University
| 3 ans |
| Naonori Kurokawa | M | - |
Osaka University
| 3 ans |
| Hiroyuki Murai | M | - |
Osaka University
| 4 ans |
| Mohammad Kamal Uddin | M | - |
Osaka University
| 3 ans |
| Adel Ibrahim Mohammad Al-Katheeri | F | 50 |
Osaka University
| - |
| Yayoi Tanaka | M | 64 |
Osaka University
| 3 ans |
| Heng Bo Yin | M | 61 |
Osaka University
| 3 ans |
| Tomoya Shimojo | M | 52 |
Osaka University
| 2 ans |
| Yasunori Tsukahara | M | 50 |
Osaka University
| 3 ans |
| Satoshi Mizukawa | M | 44 |
Osaka University
| 3 ans |
| Masanori Takeshita | M | 44 |
Osaka University
| 4 ans |
| Masaki Himeno | M | - |
Osaka University
| 6 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Vietnam | 21 | 58,33% |
| Chine | 15 | 41,67% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
